Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Century Therapeutics, Inc. (IPSC) had Normalized Income after Taxes of $-32.54M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-32.54M |
|
-- |
|
-- |
|
$34.66M |
|
$-34.66M |
|
$2.12M |
|
$-32.54M |
|
$-32.54M |
|
$-32.54M |
|
$-32.54M |
|
$-32.54M |
|
|
Normalized Income after Taxes |
$-32.54M |
$-34.66M |
|
$-32.11M |
|
86.24M |
|
86.24M |
|
$-0.38 |
|
$-0.38 |
|
| Balance Sheet Financials | |
$160.17M |
|
$56.65M |
|
$124.52M |
|
$284.69M |
|
$14.95M |
|
-- |
|
$59.85M |
|
$74.79M |
|
$209.90M |
|
$175.70M |
|
$209.90M |
|
86.32M |
|
| Cash Flow Statement Financials | |
$-62.22M |
|
$60.47M |
|
$0.12M |
|
$61.21M |
|
$59.59M |
|
$-1.63M |
|
$4.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.72 |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-63.01M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.50% |
|
-18.52% |
|
-11.43% |
|
-15.50% |
|
$2.43 |
|
$-0.73 |
|
$-0.72 |
|